Abstract
Cardiovascular diseases cause more deaths in the world. Atherosclerotic plaques cause thrombus formation in the blood vessels leads to impediment in the vascular lumen can create a complete blockage of the blood vessels which increases the risk of developing coronary artery disease. The biomarker is used to assess the biological process and pharmacological responses of the drugs to a targeted intervention. It is used to identify the disease progression burden among the affected population. The cardiovascular biomarkers include B-type natriuretic peptide, urinary NGAL, troponin, C-reactive protein, N-terminal prohormone BNP, myeloperoxidase, lipoprotein-associated phospholipase A2, cytokine IL-37, troponin, fibrinogen, metalloproteinase-1, and cystatin C is used to predict the risk of progression of cardiovascular diseases.
Keywords: Biomarker, Cardiovascular Disease, Coronary Artery Disease, Risk Prediction, Therapeutic Interventions.
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Current Drug Targets - Cardiovascular & Hematological Disorders
Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Current Cardiology Reviews
Current Hypertension Reviews
Cardiovascular & Hematological Agents in Medicinal Chemistry
Cardiovascular & Hematological Disorders-Drug Targets
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents